Traditional Chinese medicine composition used for treating polycystic ovarian syndrome
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A polycystic ovary syndrome technology, applied in the field of medicine, can solve the problems of treating the symptoms, not the root cause, and large side effects, and achieve the effects of good curative effect, safe medication, and no side effects
Inactive Publication Date: 2015-04-08
HENAN UNIV OF CHINESE MEDICINE
View PDF2 Cites 14 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
At present, most of the drugs for the treatment of polycystic ovary syndrome are western medicines, which have large side effects and treat the symptoms but not the root cause. Chinese medicine has a history of
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0008] The traditional Chinese medicine composition is composed of the following raw materials: Rehmannia glutinosa 22g, Epimedium 13g, Dodder 27g, Atractylodes macrocephala 13g, Poria cocos 13g, tangerine peel 8g, Jiang Pinellia 7g, Rhizoma Cyperi 5g, Achyranthes bidentata 13g, Salvia miltiorrhiza 27g and white mustard seed 8g .
Embodiment 2
[0010] The traditional Chinese medicine composition is composed of the following raw materials: Rehmannia glutinosa 24g, Epimedium 15g, Dodder 30g, Atractylodes macrocephala 15g, Poria cocos 15g, tangerine peel 10g, Jiang Pinellia 9g, Cyperus cyperi 6g, Achyranthes bidentata 15g, Salvia miltiorrhiza 30g and white mustard seed 10g .
Embodiment 3
[0012] The traditional Chinese medicine composition is composed of the following raw materials: Rehmannia glutinosa 26g, Epimedium 17g, Dodder 33g, Atractylodes macrocephala 17g, Poria cocos 17g, tangerine peel 12g, Jiang Pinellia 11g, Cyperus cyperi 7g, Achyranthes bidentata 17g, Salvia miltiorrhiza 33g and white mustard seed 12g .
[0013] Among the above components, among them:
[0014] Rehmannia glutinosa: enriches blood and nourishes yin, replenishes essence and marrow. For the various syndromes of blood deficiency; the various syndromes of liver and kidney yin deficiency;
[0015] Epimedium: tonifies kidney yang, strengthens muscles and bones, and dispels rheumatism. For impotence and nocturnal emission, muscle and bone flaccidity, rheumatic arthralgia, numbness and contracture; menopausal hypertension;
[0016] Cuscuta chinensis: nourishing the kidney and improving eyesight, nourishing the liver and improving eyesight, invigorating the spleen and strengthening the fe...
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention relates to a traditional Chinese medicine composition used for treating polycystic ovarian syndrome. The traditional Chinese medicine composition can effectively solve the medicine use problem of polycystic ovarian syndrome. According to the technical scheme, the traditional Chinese medicine composition is composed of 22 grams to 26 grams of prepared rehmannia roots, 13 grams to 17 grams of herba epimedii, 27 grams to 33 grams of semen cuscutae, 13 grams to 17 grams of atractylodes macrocephala, 13 grams to 17 grams of poria cocos, 8 grams to 12 grams of pericarpium citri reticulatae, 7 grams to 11 grams of ginger processed pinellia, 5 grams to 7 grams of rhizoma cyperi, 13 grams to 17 grams of medicinal cyathula roots, 27 grams to 33 grams of salviae miltiorrhizae and 8 grams to 12 grams of semen brassicae. The raw materials are abundant, scientific in component and reasonable in medicine compatibility and support one another, the traditional Chinese medicine composition is effective medicine for treating polycystic ovarian syndrome, has the effects of warming kidneys, tonifying spleens, reducing phlegm, removing blood stasis, regulating the menstruation and assisting in reproduction, is effectively used for treating polycystic ovarian syndrome, is good in curative effect, safe in medicine use, free of toxic and side effects, stable in curative effect, safe, reliable and innovative.
Description
technical field [0001] The invention relates to medicine, in particular to a traditional Chinese medicine composition for treating polycystic ovary syndrome. Background technique [0002] Polycystic ovary syndrome (PCOS) is a common endocrine syndrome in women of reproductive age. In 1935, Stein and Leventhal first described bilateral enlarged ovaries with infertility, hirsutism and obesity, which was called Stein-Leventhal syndrome. With the deepening of clinical research, the range of clinical syndromes with polycystic ovary with anovulation and (or) hirsutism in histology is expanding. In 1963, Goldziether summarized the data of 1079 cases of PCOS in 187 articles, and found that there were many atypical cases, such as no hirsutism, and even ovulation function. With the development of detection technology, it is recognized that polycystic ovary is not a unique disease, but a clinical syndrome with multiple etiologies and extremely heterogeneous manifestations. At prese...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more